Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

dollar-544956_1280

Top 5 pharma companies’ Q3 results

November 6, 2015 Medical Communications, Sales and Marketing financial results, revenue, sales

The leading pharma players have been able to report largely positive financial results to their shareholders in the third quarter …
Feature
astrazeneca image

AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results

November 6, 2015 Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers

AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …
News
Sanofi logo

Sanofi buys in new diabetes drug

November 6, 2015 Medical Communications, Research and Development, Sales and Marketing Lexicon Pharma, SGLT2, SGLT2 inhibitors, Sanofi, sotagliflozin

Sanofi has paid an initial $300 million for collaboration and license agreement to develop sotagliflozin, one of a newer class …
News
Olivier Brandicourt

Brandicourt sets out Sanofi’s long-term vision

November 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, olivier brandicourt, pharma strategy

Sanofi has pledged to plough the money saved from its business restructure into R&D investment, to bring 18 new products …
News
nsclc_merck_pfizer

Merck and Pfizer begin new Phase III avelumab trial in lung cancer

November 5, 2015 Medical Communications, Research and Development Merck, Pfizer, avelumab, lung cancer, non-small cell lung cancer

Merck and Pfizer have commenced an international Phase III study of the investigational cancer immunotherapy avelumab in patients with non-small …
News
mark_filip

Former Deputy Attorney General called in to advise Valeant after fraud allegations

November 2, 2015 Medical Communications, Sales and Marketing Mark Filip, Philidor, Valeant, fraud

Valeant Pharmaceuticals’ board of directors has appointed former Deputy Attorney General of the United States Mark Filip to advise the …
Appointment
pillsphotos1

The pharmaceutical ethics of drug-price increases

October 30, 2015 Medical Communications, Research and Development Drug pricing, Turing Pharma, ethics

What is an ‘ethical’ price for a drug?Last month Turing Pharmaceuticals, a start-up run by a former hedge-fund manager, raised …
Feature
Phase III trial

FDA approves new therapy for pancreatic cancer

October 30, 2015 Medical Communications, Sales and Marketing FDA, Pancreatic cancer

The FDA has approved drug a pancreatic cancer drug, Onivyde, which has produced significant overall survival rates in an international …
News
valeant_logo

Valeant drops Philidor after prescription fraud row

October 30, 2015 Medical Communications, Sales and Marketing Valeant

Valeant has announced that it is ‘severing all ties with Philidor’, the specialty pharmacy at the heart of recent controversy surrounding …
News

NHS set for digital health tech review

October 30, 2015 Medical Communications Jeremy Hunt, NHS, Robert Wachter, digital health, health secretary

Health secretary Jeremy Hunt says turning the NHS into a “patient-powered, technologically advanced health service” is “one of the most …
News
Project EVO

Digital software shows benefit in ADHD trial

October 30, 2015 Medical Communications ADHD, Akili, PureTech Health, attention deficit hyperactivity disorder, digital tech

A pilot study of a digital health technology designed to improve symptoms of attention deficit hyperactivity disorder (ADHD) in children …
News
faysal_kamoua

Alvogen appoints Faysal Kalmoua as EVP of portfolio

October 29, 2015 Medical Communications Alvogen, Faysal Kalmoua

Alvogen has announced the appointment of Faysal Kalmoua as its new executive vice president of portfolio.Kalmoua joins Alvogen with an …
Appointment
Constella

Allergan acquires rights to pioneering IBS treatment from Almirall

October 29, 2015 Medical Communications, Sales and Marketing Allergan, Constella, IBS, linaclotide

Allergan and its commercialisation partner Ironwood Pharmaceuticals have announced that Allergan has acquired the rights to Constella.The companies have acquired …
News
j

Valeant CEO rejects fraud accusations in conference call

October 27, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing

Valeant says it will establish a committee to review allegations about the company’s relationship with specialist pharmacy Philidor, following what …
News
cosentyx_logo

Novartis’ Cosentyx gets European approval for two conditions

October 23, 2015 Medical Communications, Sales and Marketing Cosentyx, European Medicines Agency, Novartis, psoriatic arthritis

The scientific committee of the European Medicines Agency (EMA) has recommended the approval of Novartis’ Cosentyx (secukinumab) for treatment of ankylosing …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026